189 related articles for article (PubMed ID: 32373607)
41. Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma.
DePalma TJ; Sivakumar H; Skardal A
Adv Drug Deliv Rev; 2022 Jan; 180():114067. PubMed ID: 34822927
[TBL] [Abstract][Full Text] [Related]
42. Mechanism of Ca
Turovsky EA; Varlamova EG
Biology (Basel); 2021 Aug; 10(8):. PubMed ID: 34439975
[TBL] [Abstract][Full Text] [Related]
43. Human pluripotent stem cell-derived brain organoids as in vitro models for studying neural disorders and cancer.
Luo J; Li P
Cell Biosci; 2021 May; 11(1):99. PubMed ID: 34049587
[TBL] [Abstract][Full Text] [Related]
44. Novel Tools and Investigative Approaches for the Study of Oligodendrocyte Precursor Cells (NG2-Glia) in CNS Development and Disease.
Galichet C; Clayton RW; Lovell-Badge R
Front Cell Neurosci; 2021; 15():673132. PubMed ID: 33994951
[TBL] [Abstract][Full Text] [Related]
45. Integrated genomic and transcriptomic analysis suggests
Li Z; Jin Y; Zou Q; Shi X; Wu Q; Lin Z; He Q; Huang G; Qi S
Ann Transl Med; 2021 Apr; 9(8):713. PubMed ID: 33987411
[TBL] [Abstract][Full Text] [Related]
46. A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma.
Lenin S; Ponthier E; Scheer KG; Yeo ECF; Tea MN; Ebert LM; Oksdath Mansilla M; Poonnoose S; Baumgartner U; Day BW; Ormsby RJ; Pitson SM; Gomez GA
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919246
[TBL] [Abstract][Full Text] [Related]
47. Advanced Spheroid, Tumouroid and 3D Bioprinted In-Vitro Models of Adult and Paediatric Glioblastoma.
Orcheston-Findlay L; Bax S; Utama R; Engel M; Govender D; O'Neill G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803967
[TBL] [Abstract][Full Text] [Related]
48. The adaptive transition of glioblastoma stem cells and its implications on treatments.
Wang Z; Zhang H; Xu S; Liu Z; Cheng Q
Signal Transduct Target Ther; 2021 Mar; 6(1):124. PubMed ID: 33753720
[TBL] [Abstract][Full Text] [Related]
49. Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma.
Martínez Bedoya D; Dutoit V; Migliorini D
Front Immunol; 2021; 12():640082. PubMed ID: 33746981
[TBL] [Abstract][Full Text] [Related]
50. Three-dimensional model of glioblastoma by co-culturing tumor stem cells with human brain organoids.
Azzarelli R; Ori M; Philpott A; Simons BD
Biol Open; 2021 Feb; 10(2):. PubMed ID: 33619017
[TBL] [Abstract][Full Text] [Related]
51. Evolution of Experimental Models in the Study of Glioblastoma: Toward Finding Efficient Treatments.
Gómez-Oliva R; Domínguez-García S; Carrascal L; Abalos-Martínez J; Pardillo-Díaz R; Verástegui C; Castro C; Nunez-Abades P; Geribaldi-Doldán N
Front Oncol; 2020; 10():614295. PubMed ID: 33585240
[TBL] [Abstract][Full Text] [Related]
52. Trends and challenges in modeling glioma using 3D human brain organoids.
Mariappan A; Goranci-Buzhala G; Ricci-Vitiani L; Pallini R; Gopalakrishnan J
Cell Death Differ; 2021 Jan; 28(1):15-23. PubMed ID: 33262470
[TBL] [Abstract][Full Text] [Related]
53. The Organoid Era Permits the Development of New Applications to Study Glioblastoma.
Andreatta F; Beccaceci G; Fortuna N; Celotti M; De Felice D; Lorenzoni M; Foletto V; Genovesi S; Rubert J; Alaimo A
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182346
[TBL] [Abstract][Full Text] [Related]
54. Organoid models of glioblastoma: advances, applications and challenges.
Zhang C; Jin M; Zhao J; Chen J; Jin W
Am J Cancer Res; 2020; 10(8):2242-2257. PubMed ID: 32905502
[TBL] [Abstract][Full Text] [Related]
55. Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells.
Azzarelli R
Front Cell Dev Biol; 2020; 8():220. PubMed ID: 32373607
[TBL] [Abstract][Full Text] [Related]
56. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
[TBL] [Abstract][Full Text] [Related]
57. Three-dimensional culture models to study glioblastoma - current trends and future perspectives.
Joseph JV; Blaavand MS; Daubon T; Kruyt FA; Thomsen MK
Curr Opin Pharmacol; 2021 Dec; 61():91-97. PubMed ID: 34656940
[TBL] [Abstract][Full Text] [Related]
58. Utility of the Cerebral Organoid Glioma 'GLICO' Model for Screening Applications.
Weth FR; Peng L; Paterson E; Tan ST; Gray C
Cells; 2022 Dec; 12(1):. PubMed ID: 36611949
[TBL] [Abstract][Full Text] [Related]
59. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
[TBL] [Abstract][Full Text] [Related]
60. Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma.
Sundar SJ; Shakya S; Barnett A; Wallace LC; Jeon H; Sloan A; Recinos V; Hubert CG
Transl Oncol; 2022 Jan; 15(1):101251. PubMed ID: 34700192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
